Neuronetics, Inc. understands the interconnection of mental and physical health. As a global leader in neuroscience, they’re working to redefine patient and physician expectations with their NeuroStar Advanced TMS Therapy for Mental Health. This is a drug-free, non-invasive treatment modality that can improve a person’s quality of life when they’re suffering from neuro health conditions that traditional medication hasn’t helped.
This FDA-cleared system is now approved for use with adults who have been diagnosed with major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and generalized anxiety disorder. NeuroStar is leading the way in TMS therapy today. They’re committed to transforming patients’ lives by offering an exceptional treatment that produces extraordinary results.
Understanding the Approval of This New Treatment Modality
To date, they’ve treated more than 134,000 patients and conducted over 4.8 million treatment sessions. These statistics were used by the FDA in the approval of the platform, which is now being used in over 1,000 treatment centers. Real-world data is very valuable since it offers a large sample from a diverse group of patients who are being treated in clinical practices. This data also showed that out of 664 patients, 65.5% achieved a clinically meaningful response, indicating that many people could be helped by TMS treatment.
Neuronetics, Inc. says that they wouldn’t have made it this far without the contributions of healthcare providers across the country who have partnered with them. These providers have helped build a database of real-world outcomes based on MDD and GAD. The results played a major role in NeuroStar receiving FDA clearance.
What the Approval of TMS Treatment Means
Neuronetics, Inc. focuses on designing, developing, and marketing products that improve the quality of their patients’ lives. In specific, they work with those who have neuro health disorders (e.g., drug-resistant depression, obsessive-compulsive disorder). The company calls this a “big win” for their patients and their providers. This is because many people with neuro health disorders also suffer from severe depression and thoughts of suicide. With TMS, treatment providers can prescribe something that will work to help them be less anxious. Additionally, it’s also important to note that these statistics prove that TMS therapy is safe.
This advancement is great for those suffering from MDD because they tend to have complex symptoms that can’t be easily treated with the medications we currently have available.
A Closing Word Regarding TMS Treatment for Anxiety and Depression
Many American adults today suffer from MDD. Anxiety is a common co-morbidity of MDD. The NeuroStar Advanced TMS Therapy System is now approved as a treatment modality for this condition. If you’re interested in trying it yourself, contact us at TMS Advantage in Clearwater and Pinellas County, Florida, today.
Picture Credit: Neurostar